Daily Bulletin

The Times Real Estate

.

Saxenda® recommended for approval by European Medicines Agency committee for the treatment of obesity in adolescents aged 12-17 years

  • Written by PR Newswire Asia - Daily Bulletin Au RSS

BAGSVÆRD, Denmark, March 26, 2021 /PRNewswire/ -- Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has recommended that the use of Saxenda® is expanded for the treatment of obesity in adolescents aged 12–17 years.1

Over the last 20 years, the global...

Read more: Saxenda® recommended for approval by European Medicines Agency committee for the treatment of...

Business News

Why Ignoring a Windshield Chip Could Cost You More in the Long Run

(Source) When a stone from the road jumps to your windshield, you hear the distinctive tap. You check the glass window through your reflection to discover one tiny chip that seems insignificant. A sm...

Daily Bulletin - avatar Daily Bulletin

Top Tips for Landing Your First Job in Law

Starting your legal career is an exciting milestone – one that comes with its fair share of challenges and opportunities. Whether you’re fresh out of law school or looking to secure your first offic...

Daily Bulletin - avatar Daily Bulletin

Top 10 Soft Skills Every Legal Professional Needs

In the fast-paced and complex world of law, technical expertise is only half the equation. To truly excel, legal professionals must also master a set of soft skills that enhance their ability to com...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals